Sidebar Ads

Sunday, January 6, 2019

Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene


Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene



If this proposed acquisition was a game show, it would be called "The Price Isn't Right."

Related Posts:

0 comments:

Post a Comment

Subsea fibre cables can 'listen out' for sabotage

Ways are being developed for subsea cables to "sense" whether they are being disturbed or attacked. from BBC News https://ift.tt...